Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mount Sinai Medical Center, Miami Beach, Florida, United States

  • USF College of Medicine, Tampa, Florida, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • Beth Israel Lahey Health, Burlington, Massachusetts, United States

  • Overlook Medical Center, Summit, New Jersey, United States

  • Mater Hospital Sydney, North Sydney, New South Wales, Australia

  • Monash Medical Centre Moorabbin, East Bentleigh, Victoria, Australia

  • GenesisCare St Andrews Hospital, Adelaide, Australia

  • Fiona Stanley Hospital, Murdoch, Australia

  • Institut Jules Bordet, Anderlecht, Belgium

  • GZA Ziekenhuizen, Antwerp, Belgium

  • Universitair Ziekenhuis Brussel, Brussels, Belgium

  • Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • UZ Leuven, Leuven, Belgium

  • Centre Hospitalier Universitaire de Liege Sart-Tilman, Liège, Belgium

  • GZA Ziekenhuizen, Wilrijk, Belgium

  • Centro de Oncologia - Unidade Brasília - Hospital Sírio Libanês, Brasília, Brazil

  • CIONC-Centro Integrado de Oncologia de Curitiba, Curitiba, Brazil

  • Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba, Brazil

  • CEPON - Centro de Pesquisas Oncológicas de Santa Catarina, Florianópolis, Brazil

  • Oncosite - Centro de Pesquisa Clinica e Oncologia, Ijuí, Brazil

  • Fundação Doutor Amaral Carvalho, Jaú, Brazil

  • Instituto de Cancer de Londrina, Londrina, Brazil

  • Hospital das Clínicas FMRP-USP, Riberão Preto, Brazil

  • Hospital Nossa Senhora da Conceicao, Rio Grande, Brazil

  • Ensino e Terapia de Inovação Clínica AMO-ETICA, Salvador, Brazil

  • Catarina Pesquisa Clinica, Santa Catarina, Brazil

  • CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, Brazil

  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, São José do Rio Preto, Brazil

  • ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo, Brazil

  • Clínica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda, São Paulo, Brazil

  • Beijing Hospital, Beijing, China

  • 307 Hospital of PLA, Beijing, China

    Contact: Study coordinator (Principal Investigator)
  • Fujian Cancer Hospital, Fujian, China

  • Sun Yat sen University Cancer Center, Guangzhou, China

  • Zhejiang Cancer Hospital, Hangzhou, China

  • Anhui Provincial Cancer Hospital, Hefei, China

  • Shandong Cancer Hospital, Jinan, China

  • Yunnan Cancer Hospital, Kunming, China

  • Nanchang People's Hospital, Nanchang, China

  • Jiangxi Cancer Hospital, Nanchang, China

  • The Affiliated Hospital of Qingdao University, Qingdao, China

  • Fudan University Shanghai Cancer Center, Shanghai, China

    Contact: Study coordinator (Principal Investigator)
  • Henan Cancer Hospital, Zhengzhou, China

  • Cork University Hospital, Cork, Ireland

  • St Vincent's University Hospital, Dublin, Ireland

  • St James Hospital, Dublin, Ireland

    Contact: Study coordinator (Principal Investigator)
  • Beaumont Hospital, Dublin, Ireland

    Contact: Study coordinator (Principal Investigator)
  • Galway University Hospital, Galway, Ireland

  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari, Italy

  • Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi IRCCS, Bologna, Italy

  • Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova, Italy

  • Ospedale San Raffaele, Milan, Italy

  • Humanitas Istituto Clinico Catanese, Misterbianco, Italy

  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy

  • IOV - Istituto Oncologico Veneto IRCCS, Padova, Italy

  • Nuovo Ospedale di Prato, Prato, Italy

  • Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Rome, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Contact: Study coordinator (Principal Investigator)
  • Ospedale Santa Chiara, Trento, Italy

  • Amsterdam UMC, Locatie VUMC, Amsterdam, Netherlands

  • Amphia Ziekenhuis Molengracht, Breda, Netherlands

  • Medisch Centrum Leeuwarden, Leeuwarden, Netherlands

  • Alrijne Ziekenhuis Leiden, Leiden, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Maastricht University Medical Center, Maastricht, Netherlands

  • Haga Ziekenhuis, The Hague, Netherlands

  • Elisabeth TweeSteden Ziekenhuis, Tilburg, Netherlands

  • Bernhoven Uden, Uden, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Hospital de Braga, Braga, Portugal

  • Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal

  • Fundação Champalimaud, Lisbon, Portugal

  • Centro Hospitalar de Lisboa Norte E P E Hospital de Santa Maria, Lisbon, Portugal

  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain

  • Hospital Universitario Donostia, Donostia / San Sebastian, Spain

  • Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain

  • Hospital Beata Maria Ana, Madrid, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain

  • Hospital General Universitario Morales Meseguer, Murcia, Spain

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain

  • Hospital Universitario Virgen Macarena, Seville, Spain

  • Hospital Clinico Universitario de Valencia, Valencia, Spain

  • Hospital Arnau de Vilanova de Valencia, Valencia, Spain

מובילי המחקר
  • Global Clinical Leader

    Study Director

    Daiichi Sankyo